Physician profile
Aja Harding
NPI 1881261634
$2,886.34
in general payments reported to CMS, 2019-2025
13 companies · $779 in 2025
The $779 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $98.25 · 2022: $612 · 2023: $466 · 2024: $931 · 2025: $779.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,127 · Education: $49.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,127.06 |
| Education | $49.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $447.65 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Kerecis Limited | $356.77 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Integra Lifesciences Corporation | $343.42 | 2021-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Medical Device Business Services, INC. | $305.00 | 2022 | |
| My01 INC. | $296.43 | 2023-2024 | My01 Continuous Compartmental Pressure Monitor |
| Medtronic, INC. | $261.84 | 2024-2025 | Signia, Transorb |
| Ethicon US, LLC | $219.67 | 2022-2025 | Echelon Flex |
| Acera Surgical, INC. | $186.30 | 2024 | Restrata Wound Matrix |
| Intuitive Surgical, INC. | $165.83 | 2024 | |
| Axonics, INC. | $153.77 | 2023 | Axonics |
| Organogenesis INC. | $83.61 | 2025 | Puraply Wound Matrix |
| Baudax Bio INC. | $51.07 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aja Harding listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.